
无数据
无数据
无数据
| CAS Number | 53902-12-8 |
| Catalog Number | AG003UUF(AGN-PC-0JK7A1) |
| Chemical Name | TRANILAST |
| IUPAC Name | 2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid |
| InChI | InChI=1S/C18H17NO5/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22/h3-11H,1-2H3,(H,19,20)(H,21,22)/b10-8+ |
| InChI Key | NZHGWWWHIYHZNX-CSKARUKUSA-N |
| MDL Number | MFCD00864787 |
| Molecular Formula | C18H17NO5 |
| Molecular Weight | 327.3313 |
| NSC Number | 758970 |
| SMILES | O=C(O)C1=CC=CC=C1NC(/C=C/C2=CC=C(OC)C(OC)=C2)=O |
| UNII | HVF50SMY6E |
| Synonyms | N-(3',4'-dimethoxycinnamoyl)anthranilic acid,
tranilast,
tranilast hydrate,
tranilast sodium salt,
tranilast,
53902-12-8,
Rizaben,
trans-Tranilast,
Tranilastum,
MK 341,
70806-55-2,
N-(3,4-Dimethoxycinnamoyl)anthranilic acid,
Tranilastum [INN-Latin],
Tranilast [USAN:INN:JAN],
Tranpro,
UNII-HVF50SMY6E,
SB-252218,
MK-341,
Tranilast (SB 252218),
3,4-DAA,
n-(3',4'-dimethoxycinnamoyl) anthranilic acid,
HVF50SMY6E,
MLS000028468,
C18H17NO5,
CHEBI:77572,
Anthranilic acid, N-(3,4-dimethoxycinnamoyl)-,
NZHGWWWHIYHZNX-CSKARUKUSA-N,
2-((3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid,
MFCD00864787,
(E)-2-(3-(3,4-dimethoxyphenyl)acrylamido)benzoic acid,
NCGC00018185-05,
SMR000058373,
SB 252218,
2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid,
2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzoic Acid,
2-{[(2e)-3-(3,4-Dimethoxyphenyl)prop-2-Enoyl]amino}benzoic Acid,
53902-17-3,
N-(3′,4′-Dimethoxycinnamoyl)anthranilic Acid,
2-[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enamido]benzoic acid,
Tranilast trans-,
2-({(2E)-3-[3,4-bis(methyloxy)phenyl]prop-2-enoyl}amino)benzoic acid,
Rizaben (TN),
Tranilast (trans-),
SR-01000003092,
BENZOIC ACID, 2-((3-(3,4-DIMETHOXYPHENYL)-1-OXO-2-PROPENYL)AMINO)-,
NU-3450,
AC1NQZP4,
Opera_ID_1657,
DSSTox_CID_3693,
T 0318,
2-[3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid,
DSSTox_RID_77152,
DSSTox_GSID_23693,
Lopac0_001193,
SCHEMBL29875,
BSPBio_003561,
ZINC797,
MLS000759509,
MLS001065902,
MLS001077269,
MLS001424045,
MLS002207030,
MLS006010043,
SPECTRUM1505333,
CHEMBL415324,
GTPL6326,
Tranilast (JP17/USAN/INN),
2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propen-1-yl]amino]benzoic Acid,
DTXSID7023693,
BDBM21613,
CHEBI:92320,
AOB5086,
HMS2051F05,
HMS2089L07,
HMS2094I21,
HMS2230F18,
HMS3263P07,
HMS3648A16,
HMS3676G17,
HMS3713J04,
Pharmakon1600-01505333,
BCP06359,
BCP15888,
HY-B0195,
Tox21_110836,
Tox21_501193,
2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino] benzoic acid,
AC-940,
CCG-39992,
HSCI1_000076,
NSC758970,
SBB052710,
AKOS002841076,
Tranilast, >=98% (HPLC), powder,
AN-6736,
CS-2092,
DB07615,
KS-1193,
LP01193,
NC00171,
NSC-758970,
NCGC00018185-04,
NCGC00018185-06,
NCGC00018185-08,
NCGC00018185-09,
NCGC00018185-10,
NCGC00018185-20,
NCGC00021458-04,
NCGC00021458-05,
NCGC00021458-07,
NCGC00261878-01,
Rizaben;MK 341;Tranpro;SB 252218,
BC204132,
CPD000058373,
I586,
LS-37150,
N 5',
SAM001246737,
SB252218,
SC-12181,
SBI-0051160.P003,
AB0013774,
AB2000109,
CAS-53902-12-8,
EU-0101193,
S1439,
SW197551-3,
N-(3 ,4 -dimethoxycinnamoyl)anthranilic acid,
D02027,
AB00382987-18,
AB00382987-19,
AB00382987_21,
53902-12-8,104931-56-8(sodiumsalt),
902T173,
Q-201849,
SR-01000003092-2,
SR-01000003092-4,
SR-01000003092-9,
BRD-K17849083-001-02-2,
BRD-K17849083-001-03-0,
BRD-K19533706-001-01-9,
SR-01000003092-16,
2-[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid,
(E)-2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid,
2-?[[3-?(3-?methoxy-?4-?propoxyphenyl)?-?1-?oxo-?2-?propen-?1-?yl]?amino]?-Benzoic acid,
D27,
tranilast hydrate,
Tranilast sodium,
Molecule 20,
,4&prime,
tranilast sodium salt,
N-(3&prime,
D00PVQ,
D0E6OC,
Tranilast (JAN/USAN/INN),
-Dimethoxycinnamoyl)anthranilic Acid,
C18-H17-N-O5,
CID5282230,
A5375,
N-(3',4'-dimethoxycinnamoyl)anthranilic acid,
A10942,
C012293,
Rizaben, SB 252218, MK 341, Tranpro ,Tranilast,
2-((E)-3-(3,4-dimethoxyphenyl)acrylamido)benzoic acid,
|
| Complexity | 464 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Exact Mass | 327.111g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 24 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 327.336g/mol |
| Monoisotopic Mass | 327.111g/mol |
| Rotatable Bond Count | 6 |
| Topological Polar Surface Area | 84.9A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.2 |
| Symbol: | |
| Hazard statements | H302 |
| Precautionary statements | |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

